BioCentury
ARTICLE | Clinical News

Narurapid regulatory update

April 4, 2017 9:49 PM UTC

Japan approved Narurapid hydromorphone tablets from Daiichi to treat cancer pain. The product is an immediate-release formulation of hydromorphone. Daiichi also said Japan approved Narusus hydromorpho...